|
|||||
|
|
Premature closure of a phase II study of bendamustine,mitoxantrone and rituximab for patients with untreated high‐risk follicular lymphoma due to severe haematological and infectious toxicity |
|
| Authors: | Chan Y. Cheah Loretta J. Nastoupil Peter McLaughlin Michelle A. Fanale Sattva S. Neelapu Luis E. Fayad Frederick B. Hagemeister Nathan H. Fowler |
| Affiliation: | Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA |
| Abstract: | |
| Keywords: | follicular lymphoma bendamustine rituximab mitoxantrone chemoimmunotherapy |